ORG Detects Retinal Dysfunction Before Structural Changes
-
By
-
Jim Gallagher, senior managing editor
-
July 15, 2026
-
3 min
By
Jim Gallagher, senior managing editor
July 15, 2026
by Jim Gallagher, senior managing editor
July 15, 2026
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026
New research indicates smoking doubles the risk of multiple sight-threatening conditions
May 15, 2026